GENE
Income statement / Annual
Last year (2024), Genetic Technologies Limited's total revenue was $7.66 M,
a decrease of 25.93% from the previous year.
In 2024, Genetic Technologies Limited's net income was -$12.02 M.
See Genetic Technologies Limited,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$7.66 M |
$10.35 M |
$6.79 M |
$120.55 K |
$837.87 K |
$25.44 K |
$189.25 K |
$518.51 K |
$824.59 K |
$2.01 M |
| Cost of Revenue |
$3.76 M
|
$4.34 M
|
$321.22 K
|
$361.03 K
|
$101.43 K
|
$276.27 K
|
$300.09 K
|
$492.42 K
|
$743.06 K
|
$1.33 M
|
| Gross Profit |
$3.90 M
|
$6.01 M
|
$6.47 M
|
-$240.47 K
|
$736.43 K
|
-$250.82 K
|
-$110.83 K
|
$26.09 K
|
$81.53 K
|
$685.26 K
|
| Gross Profit Ratio |
0.51
|
0.58
|
0.95
|
-1.99
|
0.88
|
-9.86
|
-0.59
|
0.05
|
0.1
|
0.34
|
| Research and Development Expenses |
$752.75 K
|
$1.28 M
|
$705.51 K
|
$3.11 M
|
$865.63 K
|
$2.36 M
|
$2.21 M
|
$2.37 M
|
$2.69 M
|
$2.85 M
|
| General & Administrative Expenses |
$10.22 M
|
$1.36 M
|
$2.18 M
|
$4.16 M
|
$2.31 M
|
$3.83 M
|
$3.02 M
|
$3.11 M
|
$3.00 M
|
$4.22 M
|
| Selling & Marketing Expenses |
$2.61 M
|
$2.95 M
|
$1.89 M
|
$1.12 M
|
$279.31 K
|
$576.08 K
|
$1.07 M
|
$2.72 M
|
$3.19 M
|
$4.50 M
|
| Selling, General & Administrative Expenses |
$12.83 M
|
$10.80 M
|
$4.07 M
|
$5.28 M
|
$2.59 M
|
$4.41 M
|
$4.08 M
|
$5.83 M
|
$6.19 M
|
$8.73 M
|
| Other Expenses |
$2.54 M
|
$45.72 K
|
-$1.49 M
|
$116.27 K
|
-$799.45 K
|
$137.27 K
|
$0.00
|
$0.00
|
$58.00 K
|
$564.82 K
|
| Operating Expenses |
$16.11 M
|
$18.11 M
|
$3.11 M
|
$7.00 M
|
$6.98 M
|
$6.18 M
|
$5.34 M
|
$8.44 M
|
$8.58 M
|
$9.27 M
|
| Cost And Expenses |
$16.21 M
|
$22.45 M
|
$3.43 M
|
$7.36 M
|
$7.08 M
|
$6.46 M
|
$5.64 M
|
$8.93 M
|
$9.32 M
|
$10.60 M
|
| Interest Income |
$119.51 K
|
$220.16 K
|
$36.26 K
|
$62.39 K
|
$22.51 K
|
$25.79 K
|
$15.22 K
|
$38.77 K
|
$67.10 K
|
$39.95 K
|
| Interest Expense |
$51.62 K
|
$29.52 K
|
$15.22 K
|
$14.05 K
|
$14.82 K
|
$20.03 K
|
$28.84 K
|
$32.00 K
|
$28.89 K
|
$264.69 K
|
| Depreciation & Amortization |
$534.89 K
|
$676.58 K
|
$578.67 K
|
$478.22 K
|
$265.93 K
|
$156.25 K
|
$303.75 K
|
$371.61 K
|
$390.07 K
|
$232.20 K
|
| EBITDA |
-$11.43 M |
-$11.20 M |
-$7.20 M |
-$6.58 M |
-$5.87 M |
-$6.25 M |
-$5.46 M |
-$7.80 M |
-$8.10 M |
-$8.42 M |
| EBITDA Ratio |
-1.49
|
-1.08
|
-1.06
|
-54.61
|
-7.01
|
-245.61
|
-28.85
|
-15.04
|
-9.83
|
-4.19
|
| Operating Income Ratio |
-1.59
|
-1.01
|
-1.11
|
-61.56
|
-7.09
|
-275.82
|
-33.84
|
-15.76
|
-10.3
|
-4.9
|
| Total Other Income/Expenses Net |
$192.99 K
|
-$1.49 M
|
-$2.35 M
|
$343.94 K
|
-$1.90 M
|
$592.26 K
|
$939.68 K
|
-$232.58 K
|
$336.12 K
|
$1.06 M
|
| Income Before Tax |
-$12.02 M
|
-$11.91 M
|
-$7.16 M
|
-$7.08 M
|
-$6.29 M
|
-$6.43 M
|
-$5.46 M
|
-$8.40 M
|
-$8.46 M
|
-$8.81 M
|
| Income Before Tax Ratio |
-1.57
|
-1.15
|
-1.05
|
-58.71
|
-7.51
|
-252.54
|
-28.87
|
-16.21
|
-10.26
|
-4.38
|
| Income Tax Expense |
$0.00
|
-$158.33 K
|
-$32.13 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$359.80 K
|
$0.00
|
| Net Income |
-$12.02 M
|
-$11.75 M
|
-$7.13 M
|
-$7.08 M
|
-$6.29 M
|
-$6.43 M
|
-$5.46 M
|
-$8.40 M
|
-$8.46 M
|
-$8.81 M
|
| Net Income Ratio |
-1.57
|
-1.14
|
-1.05
|
-58.71
|
-7.51
|
-252.54
|
-28.87
|
-16.21
|
-10.26
|
-4.38
|
| EPS |
-2.73 |
-3.6 |
-2.32 |
-2.48 |
-4.5 |
-6.9 |
-6.6 |
-12 |
-14.7 |
-24.6 |
| EPS Diluted |
-2.73 |
-3.6 |
-2.32 |
-2.48 |
-4.5 |
-6.9 |
-6.6 |
-12 |
-14.7 |
-24.6 |
| Weighted Average Shares Out |
$4.61 M
|
$3.38 M
|
$3.07 M
|
$2.85 M
|
$1.39 M
|
$941.23 K
|
$811.76 K
|
$707.21 K
|
$571.74 K
|
$357.60 K
|
| Weighted Average Shares Out Diluted |
$4.61 M
|
$3.38 M
|
$3.07 M
|
$2.85 M
|
$1.39 M
|
$941.23 K
|
$811.76 K
|
$707.21 K
|
$571.74 K
|
$357.60 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
